Scinovex
review Open AccessTop 1% cited

Histone deacetylases (HDACs): characterization of the classical HDAC family

Biochemical Journal · 2003 · Vol. 370(3) · pp. 737–749
Annemieke J.M. de RuijterAlbert H. GennipHuib N. CaronStephan KempAndré B. P. Kuilenburg

Abstract

Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly influenced by the post-translational modification of histones, the building blocks of chromatin, such as methylation, phosphorylation and acetylation. Acetylation is probably the best understood of these modifications: hyperacetylation leads to an increase in the expression of particular genes, and hypoacetylation has the opposite effect. Many studies have identified several large, multisubunit enzyme complexes that are responsible for the targeted deacetylation of histones. The aim of this review is to give a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity. SAGE (serial analysis of gene expression) data show that HDACs are generally expressed in almost all tissues investigated. Surprisingly, no major differences were observed between the expression pattern in normal and malignant tissues. However, significant variation in HDAC expression was observed within tissue types. HDAC inhibitors have been shown to induce specific changes in gene expression and to influence a variety of other processes, including growth arrest, differentiation, cytotoxicity and induction of apoptosis. This challenging field has generated many fascinating results which will ultimately lead to a better understanding of the mechanism of gene transcription as a whole.

Histone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsEpigenetics and DNA MethylationAcetylationHDAC11HistoneHistone deacetylaseChromatinBiologyHistone deacetylase 5EpigeneticsHistone-modifying enzymesRegulation of gene expression

MeSH terms

AcetylationGene Expression RegulationHistone DeacetylasesHistonesHumansIsoenzymesModels, GeneticNeoplasmsRepressor ProteinsTissue DistributionTranscription, GeneticMolecular StructureSignal TransductionEvolution, Molecular
Citations
3,077
FWCI
38.27
field-weighted impact
References
135
Percentile
100%
vs. same field & year
Citations per year
Cited by
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
British Journal of Clinical Pharmacology · 2021 · 401 citations
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
British Journal of Pharmacology · 2006 · 807 citations
HDAC family: What are the cancer relevant targets?
Cancer Letters · 2008 · 1,047 citations
Prospects: Histone deacetylase inhibitors
Journal of Cellular Biochemistry · 2005 · 478 citations
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Current Opinion in Cell Biology · 2015 · 861 citations
Oxidative stress and redox regulation of lung inflammation in COPD
European Respiratory Journal · 2006 · 923 citations
References
The fundamental role of epigenetic events in cancer
Nature Reviews Genetics · 2002 · 5,646 citations
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Nature Reviews Drug Discovery · 2002 · 1,513 citations
The Human Histone Deacetylase Family
Experimental Cell Research · 2001 · 547 citations
The language of covalent histone modifications
Nature · 2000 · 8,530 citations
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Trends in Genetics · 2000 · 1,634 citations
Histone deacetylases, transcriptional control, and cancer
Journal of Cellular Physiology · 2000 · 622 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.